Ipca Laboratories Ltd. — Board/Management Information 2019

Mar 29, 2019

March 29, 2019

THRU ONLINE FILING

BSE Limited The National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers Exchange Plaza, 5[th] Fir, Plot # C/1 27'h Floor, Dalal Street G Block, Bandra-Kurla Complex, Mumbai 400 023 Bandra (E), Mumbai 400 051 .

Dear Sirs,

Re: Changes in the composition of the Board of Directors and its Committees

1. At the meeting of the Board of Directors of the Company held today, Mr. Kamal Kishore Seth is appointed as an Additional Director / Independent Director of the Company for a period of 5 years from 29[th ] March, 2019 till 28[th ] March, 2024 (subject to the approval of. shareholders at the ensuing Annual General Meeting).

Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of Independent Director appointed:

Name: Mr. Kamal Kishore Seth (DIN 00194986) 1. Reason for Change 2. Date of appointment & term of appointment 3. Brief Profile (in case of appointment) 4. Disclosure of relationships between directors Appointed as an Independent Director For a period of 5 years from 29th March, 2019 28thMarch 2024 , Mr. Kamal Kishore Seth, aged 73 years, is Commerce and Law Graduate, Fellow of t Institute of Chartered Accountants of India, qualified Company Secretary and also has degree in Management Studies from Jamna Bajaj Institute of Management Studies. He has nearly 4 decades of experience in mu national Companies like. Wyeth, Hindust Unilever and Reliance Group in leadersh positions in the functional areas such as Financ Commercial, Marketing, Risk Managemen Business Management, Investment and Gene Management' with profit centre responsibilities multiple sectors including Drugs Pharmaceuticals, FMCG, Fiber & Petrochem'ica Energy, Infrastructure and Real Estate. Mr. S has travelled extensively and has a wide range international exposure in dealing with Fortune 5 companies. Mr. Seth is not debarred from holding the office Director by virtue of any SEBI order or order any other competent authority. Not related to any Director or Key Manageri Personnel of the Company.

till . a he a a lal lti- an ip e, t, ral in & ls, eth of 00 of by al

Ipea Laboratories Ltd. www.ipea.eom

125, Kandivli Industrial Estate, CTS No. 328, Kandivli (West), Mumbai 400 067, India I T: +91 22 62105000 F:+91 22 62105005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067, India I T: +91 2266474444 F:+91 22 28686613 E: ipca@ipca.com I CIN: L24239MH1949PLC007837

: 2:

==> picture [123 x 38] intentionally omitted <==

----- Start of picture text -----

\Q~lnca
~ ~oseoflife
----- End of picture text -----

1. The present term of appointment of Mr. Babula!. Jain as an Independent Director is coming to an end on 31[st] March, 2019. He has informed the Company of his inability to continue / be re-appointed as Independent Director / Director of the Company.

Accordingly, the Board at its meeting held today has accepted his letter and agreed to relieve him as the Director / .Independent Director of the Company with. effect from 1st April, 2019. Accordingly, he ceases to be a Director of the Company with effect from the aforesaid date.

1. Consequent to the above, the revised composition of the Board of Directors of the Company with effect from 1[st] April, 2019 will be :

Mr. Premchand Godha Chairman & Managing Director I CEO Mr. A.K. Jain Joint Managing Director / CFO Mr. Pranay Godha Executive Director Mr. Prashant Godha Executive Director Mr. Anand T. Kusre Independent Director Mr. Dev Parkash Yadava Independent Director Dr. (Ms.) Manisha Premnath Independent Director Mr. Kamal Kishore Seth Independent Director

None of the Directors of the Company are debarred from holding the office of the Director by virtue of any SEBI order or order by any other competent authority.

1. Pursuant to this, the Board has also re-constituted its following committees with. effect from 1 sl April, 2019 and the revised Board Committees will comprise of the following Board Members:

Audit Committee Mr. Anand T. Kusre Chairman of the Committee / Independent Director Mr. Dev Parkash Yadava Independent Director Mr. Kamal Kishore Seth Independent Director. Mr. Prashant Godha Executive Director Nomination and Remuneration Committee Mr. Anand 1. Kusre Chairman of the Committee /Independent Director Mr. DevParkash Yadava Independent Director Mr. Kamal Kishore Seth Independent Director Dr. (Ms.) Manisha Premnath Independent Director

Ipea Laboratories Ltd. www.ipca.com

125, Kandivli Industrial Estate, CTS No. 328, Kandivli (West), Mumbai 400 067, India I T: +91 22 62105000 F:+91" 22 62105005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067, India I T: +91 22 6647 4444 F:+91 2228686613 E: ipca@ipca.com I ClN: L24239MH1949PLC007837

: 3:

Stakeholders Relationship Committee

Mr. Kamal Kishore Seth Chairman of the Committee / Independent Director Dr. (Ms.) Manisha Premnath Independent Director Mr. Premchand Godha . Chairman & Managing Director / CEO Mr. A. K. Jain Joint Managing Director/CFO

1. CompOsition of the other Committees of the Board of Directors, however, remain unchanged.

2. Kindly note that the Board Meeting started at 4.00 p:m. and concluded at5.15 p.m.

Thanking you

Yours faithfully For Ipca Laboratories limited ~ Harish P. Kamath . Corporate Counsel & Company Secretary

Ipea Laboratories Ltd. www.ipca.com

125, Kandivli Industrial Estate, CTS No. 328, Kandivli (West), Mumbai 400 067, India I T: +91 226210 5000 F: +91 226210 5005 Regd Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067, India I T: +91 2266474444 F: +91 2228686613 . E: ipca@ipca.coml ClN: L24239MH1949PLC007837